Live Breaking News & Updates on Harmonization Guidelines

Stay updated with breaking news from Harmonization guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial | Coronavirus (COVID-19) | JAMA

This randomized clinical trial compares the effects of 3 doses of bamlanivimab monotherapy (700 vs 2800 vs 7000 mg) vs combination bamlanivimab and etesevimab v ....

United States , Eteläuomen Läi , Junshi Biosciences , Bristol Myers Squibb , Danielm Skovronsky , Eli Lilly , Monte Carlo , Van Naarden , David Mcilwain , Abcellera Biologics , Drug Administration , Institute Inc , World Health Organization , Infectious Diseases Vaccine Research Center , Gilead Sciences , National Institute Of Allergy , Emergency Use , North America , Blocking Viral Attachment , Cell Entry , International Conference , Harmonization Guidelines , Good Clinical Practice , Secondary Outcomes , Enterprise Guide , Clinical Characteristics ,

Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression | BMC Infectious Diseases

Despite sustained viral suppression with effective antiretroviral therapy (ART), HIV-infected patients with suboptimal immune recovery are still at high risk of both non-AIDS-related and AIDS-related events. The aim of this study was to investigate determinants potentially associated with suboptimal CD4 + T cell count recovery during free ART with sustained viral suppression among an HIV-infected Yi ethnicity population in Liangshan Prefecture, an area in China with high HIV prevalence. This retrospective study included HIV-infected Yi adults (≥ 18 years and baseline CD4 + T cell count less than 500 cells/μL) for whom ART supported by National Free Antiretroviral Treatment Program was initiated between January 2015 and December 2018 in Zhaojue County, Liangshan Prefecture. Virological suppression (viral load < 50 copies/mL) was achieved within 12 months after ART initiation, and sustained virological suppress ....

New York , United States , Eteläuomen Läi , Roche Cobas Taqman , Zhaojue County , Liangshan Prefecture , Liangshan Yi Autonomous Prefecture , Sichuan Province , Medical Ethics Committee , West China Hospital , Sichuan University , Annual Audit , International Conference , Harmonization Guidelines , Good Clinical ,

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial | Geriatrics | JAMA

This randomized clinical trial assesses the effect of a single intravenous infusion of bamlanivimab vs placebo on incidence of COVID-19 among residents and staf ....

United States , North Carolina , Eteläuomen Läi , Sanofi Pasteur , Van Naarden , Gomez Lorenzo , Danielm Skovronsky , Eli Lilly , National Institute Of Allergy , Melinda Gates Foundation , Covpn Operations Center , Prevention Network Co , Software Group , Laboratory Monitoring , Gilead Sciences , Group Information , National Institutes Of Health , Drug Administration , Or Foundation , Institute Inc , Council For International Organizations Of Medical Sciences , Emergency Use Authorization , International Organizations , Medical Sciences , International Conference , Harmonization Guidelines ,